Comparison Between Ropivacaine/Dexamethasone and 10% Lignocaine Injection in Distal Glossopharyngeal Nerve Block for Intractable Cancer Pain- A Randomized Trial
Sponsor study identifier
interventional
60
1 country
1
Study Start
August 23, 2019
Actual (reported)Primary Completion
January 31, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
February 28, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The study will compare the efficacy and safety of Ropivacaine/dexamethasone vs 10% lignocaine injection in distal glossopharyngeal nerve block for intractable cancer pain
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 28, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 11, 2019
Actual (reported)August 23, 2019
Actual (reported)September 11, 2019
Actual (reported)January 31, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
February 28, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Pain reduction on the basis of the Numeric rating scale (NRS).
Pain reduction on the basis of the Numeric rating scale (NRS). From 0 to 10 (No pain to highest pain)
4 weeks
Brief Pain Inventory (BPI)- short form
4 weeks
WHO Quality of Life-BREF
4 weeks
Patient Global Impression of Change (PGIC)
4 weeeks
Clinical Global Impression of Change (CGIC)
4 weeks
Analgesic requirement and rescue analgesic requirement
4 weeks
3ml of 0.75% ropivacaine and 1ml of 4mg/l dexamethasone will be injected.
4 ml of 10% lignocaine
Distal glossopharyngeal nerve in the neck will be blocked by using 0.75 % Ropivacaine/ 4mg/mL dexamethasone injection
Distal glossopharyngeal nerve in the neck will be blocked by using 10% lignocaine injection
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Grouped treatment entry
0.75 % Ropivacaine/ 4mg/mL dexamethasone injection
The registry names several treatments. This does not confirm that participants received them together or that they form a single product.
View registry recordAll India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, 110029, India
Dinesh Manoharan, MD
All India Institute of Medical Sciences
First Submitted
August 11, 2019
First Posted
September 11, 2019
Study Start
August 23, 2019
Actual (reported)Primary Completion
January 31, 2020
Estimated (date passed)PEARL PET-based Adaptive Radiotherapy Clinical Trial
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
February 28, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
September 11, 2019
Record last verified: 2019-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: